| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |